Free tool
FAERS Monitor: Chloraprep Triple Swabstick
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021555 or its brand name (Chloraprep Triple Swabstick, Chlorhexidine Gluconate, Isopropyl Alcohol). Reports on generic versions are filed under their own applications.
Reports
298
Serious
273
92% of reports
Hospitalization
79
Death reported
28
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- sinusitis211
- pain206
- lower respiratory tract infection205
- pruritus192
- rash187
- joint swelling186
- peripheral swelling180
- insomnia179
- impaired healing156
- weight increased156
- stomatitis155
- folliculitis154
- hypersensitivity153
- pyrexia153
- fatigue152
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 20 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 16 |
| 2020 | 21 |
| 2021 | 71 |
| 2022 | 76 |
| 2023 | 29 |
| 2024 | 34 |
| 2025 | 4 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,861 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| folliculitisSignal | 154 | 1052.0 | 941.1 | 158,379 |
| impaired healingSignal | 156 | 337.0 | 302.2 | 51,756 |
| lower respiratory tract infectionSignal | 205 | 319.6 | 295.9 | 64,641 |
| stomatitisSignal | 155 | 180.8 | 162.1 | 27,549 |
| sinusitisSignal | 211 | 145.6 | 135.3 | 30,244 |
| joint swellingSignal | 186 | 108.9 | 99.7 | 19,865 |
| peripheral swellingSignal | 180 | 82.6 | 75.3 | 14,511 |
| hypersensitivitySignal | 153 | 58.2 | 52.1 | 8,617 |
| weight increasedSignal | 156 | 49.2 | 44.1 | 7,392 |
| insomniaSignal | 179 | 47.5 | 43.3 | 8,194 |
| pruritusSignal | 192 | 35.3 | 32.4 | 6,476 |
| pyrexiaSignal | 153 | 31.2 | 28.0 | 4,518 |
| rashSignal | 187 | 30.3 | 27.8 | 5,377 |
| painSignal | 206 | 23.7 | 21.9 | 4,584 |
| fatigueSignal | 152 | 13.8 | 12.3 | 1,858 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.